首页 国际期刊 医学期刊 期刊详情(非官网)
400-808-1701

Cardiovascular Innovations And Applications

Cardiovascular Innovations And Applications杂志,由Compuscript出版,4 issues/year,出版语言English,ISSN:2009-8618,E-ISSN:2009-8782。

投稿咨询
Cardiovascular Innovations And Applications
Cardiovascular Innovations And Applications
Cardiovascular Innovations And Applications
SCIE

杂志介绍

JCR分区
Q2
中科院分区
4区
影响因子
2.6
CiteScore
2.6
期刊收录
SCIE

Cardiovascular Innovations And Applications(中文译名:《心血管创新与应用》),ISSN:2009-8618,EISSN:2009-8782,是Compuscript出版的国际性学术期刊,以4 issues/year形式稳定发行,2026年总发文量约30篇。该刊采用非OA开放访问,学科归属为CARDIAC & CARDIOVASCULAR SYSTEMS。该刊是医学、心脏和心血管系统领域的国际权威刊物,已被SCIE(科学引文索引扩展版)等国际主流学术数据库收录。2026年期刊影响因子达2.6,2025年期刊CiteScore为2.6,2025年期刊自引率约3.8%,在中科院期刊分区体系中位列医学大类4区,在所属学科领域具备高学术影响力与国际认可度。Cardiovascular Innovations And Applications长期聚焦医学、心脏和心血管系统及相关产业的技术应用前沿,平均审稿周期16 Weeks,审稿流程高效稳定。在稿件录用评判中,该刊将创新性与前沿性作为核心遴选标准,重点收录能够对医学、心脏和心血管系统领域的落地与发展产生实质性推动价值的研究成果。

从全球发文格局来看,USACHINA MAINLAND、Turkey、GERMANY (FED REP GER)、Australia、England、Bulgaria等为核心发文国家与地区;STATE UNIVERSITY SYSTEM OF FLORIDACAPITAL MEDICAL UNIVERSITY、ZHENGZHOU UNIVERSITY、CHONGQING MEDICAL UNIVERSITY、ADIYAMAN EDUC & RES HOSP、BOSCH、HARVARD UNIVERSITY等高校与科研机构是期刊的主要发文单位。

期刊评价

名词解释:

影响因子(Impact Factor, IF):指该期刊前两年发表的文章,在第三年的平均被引用次数。它反映了期刊的近期平均影响力和热度。

中科院分区:中科院分区表是国内主流的学术期刊分级评价工具,核心意义是建立跨学科可比的统一评价标尺,为职称评审、学位授予、科研立项等科研管理工作提供标准化量化依据,同时帮助科研人员筛选优质期刊、规避学术风险,适配国内本土化的科研评价需求。

期刊分区表

《新锐期刊分区表》(2026年3月发布)

大类学科 小类学科 Top期刊 综述期刊
医学
4区
CARDIAC & CARDIOVASCULAR SYSTEMS 心脏和心血管系统
4区

期刊分区表(2025年3月升级版)

大类学科 小类学科 Top期刊 综述期刊
医学
4区
CARDIAC & CARDIOVASCULAR SYSTEMS 心脏和心血管系统
4区

期刊分区表(2023年12月升级版)

大类学科 小类学科 Top期刊 综述期刊
医学
4区
CARDIAC & CARDIOVASCULAR SYSTEMS 心脏和心血管系统
4区

JCR分区

2025-2026年最新版

按JCI指标学科分区 收录子集 分区 排名 百分位
学科:CARDIAC & CARDIOVASCULAR SYSTEMS ESCI Q2 106 / 237

55.5

学科:CARDIAC & CARDIOVASCULAR SYSTEMS ESCI Q3 164 / 237

31.01

2024-2025年最新版

按JCI指标学科分区 收录子集 分区 排名 百分位
学科:CARDIAC & CARDIOVASCULAR SYSTEMS ESCI Q3 158 / 231

31.8

学科:CARDIAC & CARDIOVASCULAR SYSTEMS ESCI Q4 196 / 231

15.37


中国学者近期发文

1
Amino Acid Regulation in Metabolic Heart Disease: Mechanisms and Therapeutic Potentia

Author:Lu, Yingying; Li, Bin; Mbabazi, Nadine; Abbas, Khan Musawir; Lin, Pengqi; Pei, Huanan; Bao, Yifan; Zou, Lina; Gao, Feng; Yang, Feiyan; Bai, Yu; Yin, Dechun

Journal: CARDIOVASCULAR INNOVATIONS AND APPLICATIONS. 2026; Vol. 11, Issue 1, pp. -. DOI: 10.15212/CVIA.2025.0032

2
Burden of Hypertensive Disorders of Pregnancy: A Trend Study from 1990 to 2021 with Risk Factor and Dietary Analysi

Author:Zhao, Xiqing; Xu, Pengyuan; Du, Pengchong; Cui, Xiaobo; Xu, Zhuoyao; Wang, Yanyan; Zhang, Jinying; Cui, Xiaolin; Tang, Junnan

Journal: CARDIOVASCULAR INNOVATIONS AND APPLICATIONS. 2026; Vol. 11, Issue 1, pp. -. DOI: 10.15212/CVIA.2025.0037

3
Circulating TGM2 Levels as a Prognostic Biomarker for Coronary Artery Disease Severity and Major Adverse Cardiac Events in Acute Coronary Syndrom

Author:Guo, Zongsheng; Sheng, Erda; Sun, Hao; Jia, Yanyao; Zhao, Lei; Chen, Mulei; Fu, Yuan

Journal: CARDIOVASCULAR INNOVATIONS AND APPLICATIONS. 2026; Vol. 11, Issue 1, pp. 1-12. DOI: 10.15212/CVIA.2025.0036

4
Association Between Serum Uric Acid Levels and Atrial Fibrillation Burde

Author:Kong, Xiangyi; Zhou, Le; Wang, Jue; He, Liu; Xia, Shijun; Jiang, Chao; Liu, Yuanyuan; Wei, Shaobin; Li, Jingye; Dai, Wenli; Ren, Lan; Kong, Yu; Liu, Xiaoxia; Zuo, Song; Guo, Xueyuan; Li, Songnan; Jiang, Chenxi; Zhou, Ning; Tang, Ribo; Sang, Caihua; Long, Deyong; Dong, Jianzeng; Ma, Changsheng

Journal: CARDIOVASCULAR INNOVATIONS AND APPLICATIONS. 2026; Vol. 11, Issue 1, pp. -. DOI: 10.15212/CVIA.2025.0034

5
Response by Yang et al. to Letter Regarding Article Type 2 Inflammation: A Potential Clinical Link Between Asthma and Cardiovascular Disease

Author:Yang, Zhiyun; Ge, Yingying; Zuo, Rui; Wang, Jingjia; Wang, Wenyao; Shao, Chunli; Chang, Chun; Tang, Yida

Journal: CARDIOVASCULAR INNOVATIONS AND APPLICATIONS. 2026; Vol. 11, Issue 1, pp. -. DOI: 10.15212/CVIA.2025.0031

6
Research Advances in the Mechanisms of Pannexin-1 Channels in Cardiovascular Disease

Author:Wen, Qi; Guo, Qiuzhe

Journal: CARDIOVASCULAR INNOVATIONS AND APPLICATIONS. 2026; Vol. 11, Issue 1, pp. -. DOI: 10.15212/CVIA.2025.0039

7
Current Understanding and Evidence Regarding Qiliqiangxin (QLQX) in Heart Failure Treatment From Basic to Clinical Researc

Author:Cheang, Iokfai; Ni, Gehui; Lu, Xinyi; Chen, Ziqi; Yang, Ying; Zhang, Yue; Li, Qilin; Yao, Wenming; Gao, Rongrong; Li, Xinli

Journal: CARDIOVASCULAR INNOVATIONS AND APPLICATIONS. 2025; Vol. 10, Issue 1, pp. -. DOI: 10.15212/CVIA.2025.0011

8
Approaches for Localizing the Origin of PVCs in the Outflow Tract: Future Perspectives and Challenge

Author:Sui, Baiping; Ji, Yingjie; Wang, Ying; Gao, Ling; Li, Minghao

Journal: CARDIOVASCULAR INNOVATIONS AND APPLICATIONS. 2025; Vol. 10, Issue 1, pp. -. DOI: 10.15212/CVIA.2025.0006

9
Type 2 Inflammation: A Potential Clinical Link Between Asthma and Cardiovascular Disease

Author:Yang, Zhiyun; Ge, Yingying; Zuo, Rui; Wang, Jingjia; Wang, Wenyao; Shao, Chunli; Chang, Chun; Tang, Yida

Journal: CARDIOVASCULAR INNOVATIONS AND APPLICATIONS. 2025; Vol. 10, Issue 1, pp. -. DOI: 10.15212/CVIA.2025.0014

10
Identification of BTC and KLF15 in Vascular Smooth Muscle Cells as Key Biomarkers for Abdominal Aortic Aneurysm via Machine Learning and In Vitro Experiment

Author:Chen, Yifei; Huang, Honghao; Lyu, Yuyan; Wang, Yuehong; Pu, Jun

Journal: CARDIOVASCULAR INNOVATIONS AND APPLICATIONS. 2025; Vol. 10, Issue 1, pp. -. DOI: 10.15212/CVIA.2025.0012


在线咨询

Cardiovascular Innovations And Applications

国际简称:CARDIOVASC INNOV APP参考译名:心血管创新与应用

年发文量:30 CiteScore:2.6 是否预警:否 Gold OA文章占比:100.00% 研究类文章占比:63.33%
Cardiovascular Innovations And Applications